NOP Receptor Ligands and Parkinson's Disease.

Mercatelli, Daniela; Pisanò, Clarissa Anna; Novello, Salvatore; Morari, Michele

Mercatelli, Daniela; Pisanò, Clarissa Anna; Novello, Salvatore; Morari, Michele.

Afiliación

Mercatelli D; Department of Medical Sciences, Section of Pharmacology, and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy.
Pisanò CA; Department of Medical Sciences, Section of Pharmacology, and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy.
Novello S; Department of Medical Sciences, Section of Pharmacology, and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy.
Morari M; Department of Medical Sciences, Section of Pharmacology, and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy. mri@unife.it.

Handb Exp Pharmacol ; 254: 213-232, 2019.

Article en En | MEDLINE | ID: mdl-30689087

Asunto(s)

Péptidos Opioides/farmacología; Enfermedad de Parkinson; Sustancia Negra/metabolismo; Animales; Humanos; Ligandos; Ratones; Ratones Endogámicos C57BL; Péptidos Opioides/química; Péptidos Opioides/metabolismo; Enfermedad de Parkinson/fisiopatología; Ratas; Ratas Sprague-Dawley; Sustancia Negra/química; Nociceptina

Palabras clave

Compound 24; J-113397; L-DOPA; NOP; Nociceptin/Orphanin FQ; Parkinson's Disease; SB-612111; Trap-101

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Sustancia Negra / Péptidos Opioides Límite: Animals / Humans Idioma: En Revista: Handb Exp Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google